FDA.reportPublic FDA data

bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Neo-Polycin]

RxCUI
1117088
RxNorm name
bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Neo-Polycin]
Term type
SBDC
Status
Active
Updated
2026-06-16 07:09:41

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092011
Active start
092011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
0.4 UNT / 1 MGbacitracin
0.0035 MG / 1 MGneomycin
10 UNT / 1 MGpolymyxin B

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bacitracin1291
neomycin7299
polymyxin B8536

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Neo-Polycin]NAMES
RxNorm Namebacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Neo-Polycin]NAMES
TTYSBDCATTRIBUTES
RxCUI1117088CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01AAAntibioticsATC1-4polymyxin B
ATCA07AAAntibioticsATC1-4polymyxin B
ATCS01AAAntibioticsATC1-4neomycin
ATCR02ABAntibioticsATC1-4neomycin
ATCA07AAAntibioticsATC1-4neomycin
ATCS01AAAntibioticsATC1-4bacitracin
ATCR02ABAntibioticsATC1-4bacitracin
ATCS03AAAntiinfectivesATC1-4polymyxin B
ATCS02AAAntiinfectivesATC1-4polymyxin B
ATCS03AAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4neomycin
ATCB05CAAntiinfectivesATC1-4neomycin
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4neomycin
ATCJ01GBOther aminoglycosidesATC1-4neomycin
ATCJ01XXOther antibacterialsATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4neomycin
ATCJ01XBPolymyxinsATC1-4polymyxin B
FDASPLD000617AminoglycosidesCHEMhas_chemical_structureneomycin
FDASPLN0000175477Aminoglycoside AntibacterialEPChas_epcneomycin
FDASPLN0000175499Polymyxin-class AntibacterialEPChas_epcpolymyxin B
FDASPLN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTD001414BacitracinCHEMhas_ingredientbacitracin
MEDRTD009355NeomycinCHEMhas_ingredientneomycin
MEDRTD011112Polymyxin BCHEMhas_ingredientpolymyxin B
MEDRTD016470BacteremiaDISEASEmay_treatpolymyxin B
MEDRTD001424Bacterial InfectionsDISEASEmay_preventneomycin
MEDRTD004342Drug HypersensitivityDISEASEci_withbacitracin
MEDRTD004342Drug HypersensitivityDISEASEci_withpolymyxin B
MEDRTD004342Drug HypersensitivityDISEASEci_withneomycin
MEDRTD004653EmpyemaDISEASEmay_treatbacitracin
MEDRTD004761Enterocolitis, PseudomembranousDISEASEmay_treatbacitracin
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatpolymyxin B
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatneomycin
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatpolymyxin B
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatbacitracin
MEDRTD005767Gastrointestinal DiseasesDISEASEmay_treatpolymyxin B
MEDRTD006192Haemophilus InfectionsDISEASEmay_treatpolymyxin B
MEDRTD006501Hepatic EncephalopathyDISEASEmay_treatneomycin
MEDRTD015212Inflammatory Bowel DiseasesDISEASEci_withneomycin
MEDRTD007415Intestinal ObstructionDISEASEci_withneomycin
MEDRTD007674Kidney DiseasesDISEASEci_withbacitracin
MEDRTD007710Klebsiella InfectionsDISEASEmay_treatpolymyxin B
MEDRTD016920Meningitis, BacterialDISEASEmay_treatpolymyxin B
MEDRTD010032Otitis ExternaDISEASEmay_treatpolymyxin B
MEDRTD011014PneumoniaDISEASEmay_treatbacitracin
MEDRTD011552Pseudomonas InfectionsDISEASEmay_treatpolymyxin B
MEDRTD012871Skin DiseasesDISEASEmay_treatpolymyxin B
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_preventbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatneomycin
MEDRTD018461Soft Tissue InfectionsDISEASEmay_treatpolymyxin B
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD001745Urinary Bladder DiseasesDISEASEmay_treatpolymyxin B
MEDRTD014947Wounds and InjuriesDISEASEmay_treatpolymyxin B
MEDRTN0000000226Acid-Base ActivityMOAhas_moapolymyxin B
MEDRTN0000009954Cell Membrane Fusion Complex InteractionsMOAhas_moabacitracin
MEDRTN0000000227Cholinergic Nicotinic AntagonistsMOAci_moapolymyxin B
MEDRTN0000000163Enzyme InteractionsMOAhas_moabacitracin
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moaneomycin
MEDRTN0000008346Cellular Structure AlterationPEhas_pepolymyxin B
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTN0000008841Decreased Protein SynthesisPEhas_peneomycin
MEDRTN0000008953Decreased Striated Muscle ContractionPEci_pepolymyxin B

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBDC
CODESRxCUI1117088
NAMESRXNAV_STRbacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Neo-Polycin]
NAMESRxNorm Namebacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Neo-Polycin]